MARKETWATCH FRONT PAGE U.S. stock futures surged on Tuesday, with investors set to return from the long Memorial Day weekend. News that human trials have begun for a potential coronavirus vaccine cheered investors. See full…
French pharmaceutical giant Sanofi has riled Paris by saying the US would be first in line to receive any COVID-19 vaccine. CEO Paul Hudson told Bloomberg that Washington would get priority because it had been…
A vaccine for Coronavirus could be approved in a year in an “optimistic” scenario, the European Medicines Association (EMA) said on Thursday. “For vaccines, since the development has to start from scratch … we might…
The only way to develop and deploy a COVID-19 vaccine at the pace and scale that the current crisis demands is through international coordination. Unlike national-level strategies, a collective approach both minimizes the risks and…
President Donald Trump said on Friday that he’s hopeful to have a coronavirus vaccine on the market by the end of the year or shortly thereafter. “We’re looking to get it (a vaccine) by the…
Aaron Barker Aaron Barker has been a senior digital editor at KPRC 2 since 2016. As a meteorologist, he specializes in stories about the weather. He has covered Hurricane Harvey, the Astros first World Series…
Worldwide, there are numerous efforts underway to create a vaccine for COVID-19. Without one, we are likely to see some form of social distancing in place for the foreseeable future. And experts like Anthony Fauci,…
A coronavirus vaccine being developed by Oxford University will enter human trials as early as this Thursday, according to the U.K.’s health secretary. The U.K. government will provide £20 million ($24 million) to the university’s…